ATOSSA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Atossa Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q2 2024.
  • Atossa Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 125M shares, a 0.95% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 125M -1.2M -0.95% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 126M -1.12M -0.88% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 125M -1.32M -1.04% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 125M -1.32M -1.04% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 127M -119K -0.09% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 127M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 127M +110 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 127M +459 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 127M +699K +0.56% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 127M +5.8M +4.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 127M +79.1M +166% Dec 31, 2021 10-K 2023-03-22
Q3 2021 127M +116M +1110% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 126M +117M +1253% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 121M +112M +1223% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 47.6M +38.4M +421% Dec 31, 2020 10-K 2022-02-28
Q3 2020 10.5M +1.33M +14.6% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 9.3M +174K +1.91% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 9.13M +8.81K +0.1% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 9.13M +3.28M +56.2% Dec 31, 2019 10-K 2021-03-31
Q3 2019 9.13M +3.61M +65.3% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 9.13M +4.26M +87.3% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 9.12M +6.47M +244% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 5.85M +3.19M +120% Dec 31, 2018 10-K 2020-03-26
Q3 2018 5.52M -8.5M -60.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 4.87M -5.16M -51.4% Jun 30, 2018 10-Q/A 2018-11-13
Q1 2018 2.65M -1.13M -30% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 2.65M -1.13M -30% Dec 31, 2017 10-K 2019-03-28
Q3 2017 14M +10.2M +270% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 10M -29.5M -74.6% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 3.79M -35M -90.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 3.79M -28.9M -88.4% Dec 31, 2016 10-K 2018-03-08
Q3 2016 3.79M -26.7M -87.6% Sep 30, 2016 10-Q/A 2017-03-21
Q2 2016 39.6M +10.5M +36.2% Jun 30, 2016 10-Q/A 2017-03-21
Q1 2016 38.8M +11.6M +42.6% Mar 31, 2016 10-Q/A 2017-03-21
Q4 2015 32.7M +8.09M +32.9% Dec 31, 2015 10-Q/A 2017-03-21
Q3 2015 30.4M +5.88M +23.9% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 29M +4.6M +18.8% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 27.2M +2.79M +11.4% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 24.6M +5.99M +32.2% Dec 31, 2014 10-K 2016-03-30
Q3 2014 24.6M +7.12M +40.8% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 24.4M +9.11M +59.4% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 24.4M +9.92M +68.4% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 18.6M +5.65M +43.8% Dec 31, 2013 10-K 2015-03-30
Q3 2013 17.4M +5.33M +43.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 15.3M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 14.5M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 12.9M +1.66M +14.8% Dec 31, 2012 10-K 2014-03-27
Q3 2012 12.1M Sep 30, 2012 10-Q/A 2013-01-22
Q4 2011 11.3M Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.